We are live on ! Find out more
KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

90 hedge funds and large institutions have $375M invested in Chinook Therapeutics, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 38 increasing their positions, 20 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

518% more call options, than puts

Call options by funds: $674K | Put options by funds: $109K

90% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 20

89% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 9

24% more capital invested

Capital invested by funds: $301M → $375M (+$73.7M)

10% more funds holding

Funds holding: 82 → 90 (+8)

Holders
90
Holders Change
+8
Holders Change %
+9.76%
% of All Funds
2.24%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
17
Increased
38
Reduced
20
Closed
9
Calls
$674K
Puts
$109K
Net Calls
+$565K
Net Calls Change
-$121K

Top Buyers

Rank Fund Capital Flow
1
HMC
Harvard Management Company
Massachusetts
+$77.5M
2
State Street
State Street
Massachusetts
+$8.88M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$4.05M
4
BlackRock
BlackRock
New York
+$3.18M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$3.01M

Top Sellers

Rank Fund Capital Flow
1
ORI
Oak Ridge Investments
Illinois
-$2.96M
2
NC
Nexthera Capital
New York
-$1.77M
3
BI
BVF Inc
California
-$1.37M
4
CM
Crestline Management
Texas
-$1.25M
5
Jennison Associates
Jennison Associates
New York
-$909K
Name Holding Trade Value Shares
Change 		Change in
Stake
USAA
26
United Services Automobile Association
Texas
$1.84M +$50.7K +854 +3%
FP
27
Foundry Partners
Minnesota
$1.18M -$3.8K -64 -0.3%
VIA
28
Vident Investment Advisory
Georgia
$1.17M +$32.8K +552 +3%
TCIM
29
TIAA CREF Investment Management
New York
$1.14M +$14.1K +237 +1%
AC
30
Ascend Capital
California
$1.08M +$1.2M +20,252 New
Point72 Asset Management
31
Point72 Asset Management
Connecticut
$1.02M +$1.14M +19,220 New
TA
32
Teachers Advisors
New York
$807K +$38.9K +655 +5%
AA
33
ALPS Advisors
Colorado
$783K +$123K +2,075 +16%
Wells Fargo
34
Wells Fargo
California
$776K +$456K +7,683 +112%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$736K -$36K -606 -4%
Barclays
36
Barclays
United Kingdom
$634K +$449K +7,560 +175%
ARTA
37
A.R.T. Advisors
New York
$590K +$468K +7,880 +246%
PP
38
PDT Partners
New York
$537K +$5.47K +92 +0.9%
Swiss National Bank
39
Swiss National Bank
Switzerland
$536K – – –
Allianz Asset Management
40
Allianz Asset Management
Germany
$516K +$575K +9,681 New
AllianceBernstein
41
AllianceBernstein
Tennessee
$493K – – –
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$485K +$7.61K +128 +1%
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$484K -$68.9K -1,160 -11%
ProShare Advisors
44
ProShare Advisors
Maryland
$479K +$65.7K +1,105 +14%
DekaBank Deutsche Girozentrale
45
DekaBank Deutsche Girozentrale
Germany
$409K – – –
CS
46
Credit Suisse
Switzerland
$409K +$281K +4,732 +160%
Manulife (Manufacturers Life Insurance)
47
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$375K +$15K +253 +4%
UBS Group
48
UBS Group
Switzerland
$343K +$367K +6,177 +2,340%
Citigroup
49
Citigroup
New York
$337K +$373K +6,270 +11,611%
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$330K – – –
1
2
3 4

KDNY Hedge Fund Activity: Q3 2017 in Review

90 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Chinook Therapeutics, Inc. Common Stock (KDNY) for Q3 2017, worth a combined $375M — up 24% from $301M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new KDNY positions and 9 closed out — a net gain of 8 holders — while 38 added to existing stakes and 20 trimmed.

The largest buyer was Harvard Management Company, opening a new position worth an estimated $77.5M. The largest seller was Oak Ridge Investments, cutting an estimated $2.96M.

  • 90 institutional investors held Chinook Therapeutics, Inc. Common Stock (KDNY) as of Q3 2017, up from 82 in Q2 2017.
  • Funds reported $375M of Chinook Therapeutics, Inc. Common Stock stock for Q3 2017, up 24% quarter-over-quarter.
  • 17 funds opened new Chinook Therapeutics, Inc. Common Stock positions in Q3 2017 and 9 closed out, a net change of +8 holders.
  • The largest Chinook Therapeutics, Inc. Common Stock buyer in Q3 2017 was Harvard Management Company, an estimated $77.5M added.
  • The largest Chinook Therapeutics, Inc. Common Stock seller in Q3 2017 was Oak Ridge Investments, an estimated $2.96M sold.

Based on aggregated 13F filings for Q3 2017.